OBJECTIVE: (1) To explore to what degree prostate cancer (PC) patients felt they had participated in treatment decision making (TDM). (2) To determine whether perceived roles during TDM were associated with medical and sociodemographic variables. (3) To examine to what extent satisfaction with TDM was related to perceived role or medical and sociodemographic variables. METHODS: Patients (n=126) were recruited in hospitals and from the Dutch PC patient organization. The relationship between patients' role and stage of disease, treatment modality, age, social status and education was determined, as well as patients' satisfaction with TDM. RESULTS: Most patients felt they had participated in TDM (autonomous 18%, collaborative 60%). Older patients and those with advanced disease more frequently reported not having been involved in decision making. Satisfaction with TDM was related to age and role in TDM but not to stage of disease or treatment modality. Younger men were least content when they had not been involved in decision making. CONCLUSION: Patients' level of participation and satisfaction with TDM appears to be related to medical and sociodemographic variables. PRACTICE IMPLICATIONS: Satisfaction with TDM may be related to patients' age and assumed role. It is recommended to take this into account when planning treatment for prostate cancer patients.
OBJECTIVE: (1) To explore to what degree prostate cancer (PC) patients felt they had participated in treatment decision making (TDM). (2) To determine whether perceived roles during TDM were associated with medical and sociodemographic variables. (3) To examine to what extent satisfaction with TDM was related to perceived role or medical and sociodemographic variables. METHODS:Patients (n=126) were recruited in hospitals and from the Dutch PC patient organization. The relationship between patients' role and stage of disease, treatment modality, age, social status and education was determined, as well as patients' satisfaction with TDM. RESULTS: Most patients felt they had participated in TDM (autonomous 18%, collaborative 60%). Older patients and those with advanced disease more frequently reported not having been involved in decision making. Satisfaction with TDM was related to age and role in TDM but not to stage of disease or treatment modality. Younger men were least content when they had not been involved in decision making. CONCLUSION:Patients' level of participation and satisfaction with TDM appears to be related to medical and sociodemographic variables. PRACTICE IMPLICATIONS: Satisfaction with TDM may be related to patients' age and assumed role. It is recommended to take this into account when planning treatment for prostate cancerpatients.
Authors: Louie E Ross; Daniel L Howard; Janice V Bowie; Roland J Thorpe; Ballington L Kinlock; Carol Burt; Thomas A LaVeist Journal: J Cancer Educ Date: 2016-06 Impact factor: 2.037
Authors: Tammy Jiang; Christian H Stillson; Craig Evan Pollack; Linda Crossette; Michelle Ross; Archana Radhakrishnan; David Grande Journal: J Am Board Fam Med Date: 2017 Mar-Apr Impact factor: 2.657
Authors: Lixin Song; Ronald C Chen; Jeannette T Bensen; George J Knafl; Matthew E Nielsen; Laura Farnan; Eric M Wallen; Merle Mishel; Raj S Pruthi; James L Mohler; Paul A Godley Journal: Cancer Date: 2012-07-11 Impact factor: 6.860
Authors: Lynda G Balneaves; Tracy L O Truant; Mary Kelly; Marja J Verhoef; B Joyce Davison Journal: Support Care Cancer Date: 2007-07-03 Impact factor: 3.603